Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of BIA 2-093 on Digoxin PK in Healthy Volunteers
NCT02172742Phase 1Completed
- Sponsor
- BIAL
- Start
- May 2002
- Primary completion
- Jul 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in epilepsy comparing BIA 2-093 + Digoxin with Placebo + Digoxin (2 arms). Primary endpoint: Maximum Steady-state Plasma Concentration at Day 8. Started May 2002; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT02172742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02172742.